Ponce de Leon's fountain: Stem cells and the regenerating heart

American Journal of the Medical Sciences

Volumn 329, Issue 4, 2005, Pages 190-201

  Garry, Daniel J ^a,b   Masino, Amanda M ^a   Naseem, R Haris ^a,b   Martin, Cindy M ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Abcg2; Cardiac stem cells; Cell based therapies; Myocardial regeneration; SP cells

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN;

CELL SUBPOPULATION; CELL TRANSFER; CHRONIC DISEASE; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; EMBRYONIC STEM CELL; EXPERIMENTAL ANIMAL; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; HEART; HEART DEVELOPMENT; HEART FAILURE; HEART TRANSPLANTATION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN EMBRYO; IMMUNOCYTOCHEMISTRY; KNOCKOUT MOUSE; MOUSE MUTANT; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PHENOTYPE; POSTNATAL DEVELOPMENT; PROTEIN EXPRESSION; STEM CELL TRANSPLANTATION; SURVIVAL RATE; SURVIVAL TIME; TISSUE REGENERATION; TREATMENT INDICATION; XENOTRANSPLANTATION;

EID: 17244368309     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200504000-00005     Document Type: Conference Paper

References (73)

1. Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348:2007-18.
2. Packer M, Bristow M, Cohn J, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-55.
3. Sharpe N, Doughty R. Epidemiology of heart failure and ventricular dysfunction. Lancet 1998;352(S1):3-7.
4. Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med 1998;339:1522-33.
5. Jaski BE, Kim JC, Naftel DC, et al. Cardiac transplant outcome of patients supported on LVAD vs intravenous inotropic therapy. J Heart Lung Transplant 2001;20:449-56.
6. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a LVAD for end-stage heart failure. N Engl J Med 2001;345:1435-43.
7. Brockes JP, Kumar A. Plasticity and reprogramming of differentiated cells in amphibian regeneration. Nat Rev Mol Cell Biol 2002;3:566-74.
8. Kumar A, Velloso CP, Imokawa Y, Brockes J. Plasticity of retrovirus-labelled myotubes in the newt limb regeneration blastema. Dev Biol 2000; 2000;218:125-36.
9. Brockes JP, Kumar A, Velloso CP. Regeneration as an evolutionary variable. J Anat 2001;199:3-11.
10. Poss KD, Wilson LG, Keating MT. Heart regeneration in zebrafish. Science 2002;298:2188-90.
11. Poss KD, Keating MT, Nechiporuk A. Tales of regeneration in zebrafish. Dev Dyn 2003;226:202-10.
12. Clark L, Clark RK, Heber-Katz E. A new murine model for mammalian wound repair and regeneration. Clin Immunol Immunopath 1998;88:35-45.
13. Leferovich J, Bedelbaeva K, Samulewicz S, et al. Heart regeneration in adult MRL mice. Proc Natl Acad Sci 2001;98:9830-5.
14. Fuchs E, Segre JA. Stem cells: a new lease on life. Cell 2000;100:143-55.
15. Weissman IL. Stem cells: units of development, units of regeneration and units in evolution. Cell 2000;100:157-68.
16. Evans M, Kaufman M. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981;292:154-6.
17. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Nat Acad Sci U S A 1981;78:7634-8.
18. Rossant J. Stem cells from the mammalian blastocyst. Stem Cells 2001;19:477-82.
19. Garry DJ, Masino AM, Meeson AP, et al. Stem cell biology and therapeutic applications. Curr Opin Nephrol Hyperten 2003;12:447-54.
20. Beddington R, Robertson E. An assessment of the developmental potential of embryonic stem cells in the midgestation mouse embryo. Development 1989;105:733-7.
21. Thomas KR, Capecchi MR. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 1987;51:503-12.
22. Mansour SL, Thomas KR, Capecchi MR. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 1988;336:348-52.
23. Doetschman T, Maeda N, Smithies O. Targeted mutation of the Hprt gene in mouse embryonic stem cells. Proc Natl Acad Sci U S A 1988;85:8583-7.
24. Thomson JA, Itskovitzeldor J, Shapiro S, et al. Embronic stem cell lines derived from human blastocysts. Science 1998;282:1145-57.
25. Zwaka TP, Thomson JA. Homologous recombination in human embryonic stem cells. Nat Biotechnol 2003;21:319-21.
26. Ma Y, Ramezani A, Lewis R, et al. High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells 2003;21:111-7.
27. Richards M, Fong C-Y, Chan W-K, et al. Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nature Biotechnol 2002;20:933-6.
28. Hawke T, Garry DJ. Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 2001;91:534-51.
29. McKay R. Stem cells in the central nervous system. Science 1997;276:66-71.
30. Weissman IL. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 2000;287:1442-6.
31. Jiang Y, Jahagirdar BN, Reinhardt R, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-9.
32. Krause DS, Theise ND, Collector MI, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001;105:369-77.
33. Bjornson C, Rietze R, Reynolds B, et al. Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science 1999;283:534-7.
34. Clarke DL, Johansson C, Wilbertz J, et al. Generalized potential of adult neural stem cells. Science 2000;288:1660-3.
35. Ferrari G, De Angelis G, Coletta M, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998;279:1528-30.
36. Gussoni E, Soneoka Y, Strickland C, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999;401:390-4.
37. Jackson K, Mi T, Goodell M. Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci U S A 1999;96:25:14482-6.
38. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5.
39. Malouf M, Coleman W, Grisham JW, et al. Adult derived stem cells from the liver become myocytes in the heart in vivo. Am J Pathol 2001;158:1929-35.
40. Odelberg SJ, Kollhoff A, Keating MT. Dedifferentiation of mammalian myotubes induced by msx1. Cell 2000;103:1099-1109.
41. Terada N, Hamazaki T, Oka M, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002;416:542-5.
42. Ying Q-L, Nichols J, Evans EP, et al. Changing potency by spontaneous fusion. Nature 2002;416:545-8.
43. Anderson DJ, Gage FH, Weissman IL. Can stem cells cross lineage boundaries? Nat Med 2001;7:393-5.
44. Krause DS, Thiese ND, Collector MI, et al. Multi-organ, multi-lineage engraftment by a single bone-marrow derived stem cell. Cell 2001;105:369-70.
45. Wagers AJ, Sherwood RI, Christensen JL, et al. Little evidence for developmental plasticity of adult hematopoetic stem cells. Science 2002;297:2256-9.
46. Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001;107:1395-1402.
47. Quaini F, Urbanek K, Beltrami AP, et al. Chimerism of the transplanted heart. N Engl J Med 2002;346:5-15.
48. Laflamme MA, Myerson D, Saffitz JE, et al. Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res 2002;90:634-40.
49. Glaser R, Lu MM, Narula N, et al. Smooth muscle cells, but not myocytes of host origin in transplanted human hearts. Circulation 2002;106:17-9.
50. Martin CM, Meeson AP, Robertson SM, et al. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Biol 2004;265:262-75.
51. Oh H, Bradfute SB, Gallardo TD, et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 2003;100:12313-8.
52. Beltrami A, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003;114:763-76.
53. Goodell M, Brose K, Paradis G, et al. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996;183:1797-1806.
54. Goodell M, Rosenzweig M, Kim H, et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 1997;3:12:1337-45.
55. Asakura A, Rudnicki MA. Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation. Exp Hematol 2002;30:1339-45.
56. Preffer FI, Dombkowski D, Sykes M, et al. Lineage negative side population (SP) cells with restricted hematopoietic capacity circulate in normal human adult blood: immunophenotypic and functional characterization. Stem Cells 2002;20:417-27.
57. Lechner A, Leech CA, Abraham EJ, et al. Nestin-positive progenitor cells derived from adult human pancreatic islets of Langerhans contain side population (SP) cells defined by expression of the ABCG2 ATP binding cassette transporter. Biochem Biophys Res Com 2002;293:670-4.
58. Uchida N, Fujisaki T, Eaves AC, et al. Transplantable hematopoietic stem cells in human fetal liver have a CD34+ side population (SP) phenotype. J Clin Invest 2001;108:1071-7.
59. Sharenberg CW, Harkey MA, Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 2002;99:507-12.
60. Bunting K. ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells 2002;20:11-20.
61. Zhou S, Schuetz JD, Bunting KD, et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nature Med 2001;7:9:1028-34.
62. Litman T, Druley T, Stein W, et al. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol Life Sci 2001;58:931-9.
63. Rosenthal N. Prometheus's vulture and the stem-cell promise. N Engl J Med 2003;349:267-74.
64. Goldman JM, Horowitz MM. The international bone marrow transplant registry. Int J Hematol 2002;76:393-7.
65. Horowitz MM, Loberiza FR, Bredeson CN, et al. Transplant registries: guiding clinical decisions and improving outcomes. Oncology (Huntingt) 2001;15:649-59.
66. Smits PC, Van Geuns E, Poldermans D, et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure. J Am Coll Cardiol 2003;42:2063-9.
67. Pagani FD, DerSimonian H, Zawadzka A, et al. Autologous skeletal myoblasts transplanted to ischemia damaged myocardium in humans. J Am Coll Cardiol 2003;41:879-88.
68. Menasche P, Hagege AA, Scorsin M, et al. Myoblast transplantation for heart failure. Lancet 2001;357:279-80.
69. Perin EC, Dohmann H, Borojevic R, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003;107:2294-2302.
70. Tse HF, Kwong YL, Chan J, et al. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003;361:47-8.
71. Stamm C, Westphal B, Kleine HD, et al. Autologous bone marrow stem cell transplantation for myocardial regeneration. Lancet 2003;361:45-6.
72. Fuchs S, Satler LF, Kornowski R, et al. Catheter based autologous bone marrow myocardial injection in no option patients with advanced coronary artery disease. J Am Coll Cardiol 2003;41:1721-4.
73. Assmus B, Schachinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002;106:3009-17.